US Drug Recall Register
Class II · Moderate risk Terminated Initiated Mar 20, 2013 (13 years ago)

Mitomycin

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

What was recalled

Mitomycin (modified) 0.02% solution, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

Recalling firm
Clinical Specialties Compounding Pharmacy
Origin
GA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-657-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Mitomycin recalls

See all
Class II · Moderate risk Terminated

Mitomycin Injection Solution

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0102-2023
Class II · Moderate risk Terminated

Mitomycin 0.4mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0224-2023
Class II · Moderate risk Terminated

Mitomycin 0.2mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0223-2023
Class II · Moderate risk Ongoing

MITOMYCIN INJECTION 0.375 mg/mL SYR

Reason Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Pharmacy Plus, Inc. dba Vital Care Compounder D-0039-2023
Class II · Moderate risk Terminated

Mitomycin-C

Reason Lack of Assurance of Sterility

Edge Pharma, LLC NDC 05446-1011-01 D-0409-2022